These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35777692)

  • 1. Association of the Surgical Technique With the Structural Valve Deterioration of a Bioprosthesis: A Prospective Cohort Study.
    Escalera A; Pascual I; Hernandez-Vaquero D; Formica F; Casares J; Diaz R; Alvarez R; Callejo F; Morales C; Moris C; Silva J
    Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):647-655. PubMed ID: 35777692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term durability after surgical aortic valve replacement with the Trifecta and the Intuity valve-a comparative analysis.
    Werner P; Coti I; Kaider A; Gritsch J; Mach M; Kocher A; Laufer G; Andreas M
    Eur J Cardiothorac Surg; 2022 Jan; 61(2):416-424. PubMed ID: 34738111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of postoperative patient-prosthesis mismatch as a risk factor for early structural valve deterioration after aortic valve replacement with Trifecta bioprosthesis.
    Wakami T; Koizumi S; Koyama T
    J Cardiothorac Surg; 2022 Jul; 17(1):174. PubMed ID: 35804395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure Cusp Tear of Trifecta Bioprosthesis 2 Years after Aortic Valve Replacement.
    Hamamoto M; Kobayashi T; Ozawa M; Yoshimura K
    Ann Thorac Cardiovasc Surg; 2017 Jun; 23(3):157-160. PubMed ID: 27980283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration.
    Urso S; Calderón P; Sadaba R; Mahillo I; Tuñón J; Aldamiz G; Fraile J
    J Card Surg; 2014 Jul; 29(4):439-44. PubMed ID: 24773571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study.
    Bavaria JE; Desai ND; Cheung A; Petracek MR; Groh MA; Borger MA; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):590-7. PubMed ID: 23477687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Mitroflow bioprosthesis structural valve deterioration on cardiac morbidity.
    Waziri F; Karunanithi Z; Løgstrup BB; Hjortdal V; Nielsen PH; Poulsen SH
    J Cardiothorac Surg; 2019 Mar; 14(1):62. PubMed ID: 30885227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trifecta Versus Perimount Magna Ease Aortic Valve Prostheses.
    Biancari F; Valtola A; Juvonen T; Husso A; Dahlbacka S; Laakso T; Jalava MP; Tauriainen T; Ahvenvaara T; Kinnunen EM; Niemelä M; Mäkikallio T; Eskola M; Virtanen MPO; Maaranen P; Rosato S; Anttila V; Vento A; Airaksinen J; Raivio P
    Ann Thorac Surg; 2020 Sep; 110(3):879-888. PubMed ID: 32061588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early structural valve deterioration of a Trifecta bioprosthesis: a minimally invasive redo approach.
    Gavalaki A; Roussakis A; Perreas K
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1228. PubMed ID: 31746989
    [No Abstract]   [Full Text] [Related]  

  • 10. Two cases of catastrophic deterioration and multiple leaflet detachment in Trifecta valves.
    Imai N; Kaminishi Y; Tsukada T; Osaka M; Sakamoto H; Mathis BJ; Suzuki Y; Hiramatsu Y
    Gen Thorac Cardiovasc Surg; 2022 Mar; 70(3):292-294. PubMed ID: 35038125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten years' experience with the sutureless aortic valve replacement: incidence and predictors for survival and valve durability at follow-up.
    Pollari F; Mamdooh H; Hitzl W; Grossmann I; Vogt F; Fischlein T
    Eur J Cardiothorac Surg; 2023 Feb; 63(2):. PubMed ID: 36534823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early structural valve deterioration and reoperation associated with the mitroflow aortic valve.
    Axtell AL; Chang DC; Melnitchouk S; Jassar AS; Tolis G; Villavicencio MA; Sundt TM; D'Alessandro DA
    J Card Surg; 2018 Dec; 33(12):778-786. PubMed ID: 30525247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Incidence and Reasons for Re-intervention After Aortic Valve Replacement Using the Trifecta Aortic Bioprosthesis.
    Fard A; Mahmood Z; Nair S; Shaikhrezai K; Al-Attar N
    Curr Probl Cardiol; 2023 Jun; 48(6):101125. PubMed ID: 35114295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural valve deterioration of the Labcor Dokimos aortic prosthesis: a single-centre experience.
    Iskandarani D; Chaabo O; Gharzeddine W; Sfeir P; Obeid M; Ghazzal Z; Rebeiz A; Sawaya FJ
    Interact Cardiovasc Thorac Surg; 2022 Jun; 34(6):966-973. PubMed ID: 34687533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural valve deterioration of bioprosthetic aortic valves: An underestimated complication.
    Sénage T; Gillaizeau F; Le Tourneau T; Marie B; Roussel JC; Foucher Y
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1383-1390.e5. PubMed ID: 30415900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porcine bioprostheses for surgical aortic valve replacement: very long-term performance of a third-generation device.
    Anselmi A; Tomasi J; Aymami M; Mancini J; Nesseler N; Langanay T; Flecher E; Verhoye JP
    J Cardiovasc Med (Hagerstown); 2023 Aug; 24(8):514-521. PubMed ID: 37409596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real Structural Valve Deterioration of the Mitroflow Aortic Prosthesis: Competing Risk Analysis.
    Díaz R; Hernández-Vaquero D; Silva J; Pascual I; de la Hera JM; León V; Martín M; Barriales V; Colunga S; Del Valle R; Morís C
    Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1074-1081. PubMed ID: 28465144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful transcatheter aortic valve in valve implantation for degenerated trifecta bioprosthesis in a patient with a coronary anomaly.
    Yamagata A; Domoto S; Tanaka K; Inagaki Y; Otsuki H; Hayakawa M; Yamaguchi J; Hagiwara N; Niinami H
    Gen Thorac Cardiovasc Surg; 2021 Jul; 69(7):1137-1139. PubMed ID: 33768497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.
    Durand E; Sokoloff A; Urena-Alcazar M; Chevalier B; Chassaing S; Didier R; Tron C; Litzler PY; Bouleti C; Himbert D; Hovasse T; Bar O; Avinée G; Iung B; Blanchard D; Gilard M; Cribier A; Lefevre T; Eltchaninoff H
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007597. PubMed ID: 30998397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.